Atorvastatin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Atorvastatin. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Edema | 10.8% |
| Headache | 7.8% |
| Palpitations | 4.5% |
| Fatigue | 4.5% |
| Dizziness | 3.4% |
| Nausea | 2.9% |
| Flushing | 2.6% |
| Abdominal pain | 1.6% |
| Somnolence | 1.4% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
CADUET (amlodipine and atorvastatin) is indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate. Amlodipine1. Hypertension : Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents; 2. Coronary Artery Disease (CAD) Chronic Stable Angina: Amlodipine is indicated for the treatment of chronic stable angina. Amlodipine may be used alone or in combination with other antianginal or antihypertensive agents; Vasospastic Angina (Prinzmetal's or Variant Angina): Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. Amlodipine may be used as monotherapy or in combination with other antianginal drugs. Angiographically Documented CAD: In patients with recently documented CAD by angiography and without heart failure or an ejection fraction less than 40%, amlodipine is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary revascularization procedure. AND AtorvastatinTherapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased…
Medical disclaimer: Always consult a qualified healthcare professional about any medication.